Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children
JAMA Cardiology Dec 16, 2021
Dionne A, Sperotto F, Chamberlain S, et al. - Cardiac imaging findings in children with myocarditis after COVID-19 vaccination are described.
A case series of 15 children (14 male patients [93%]; median age, 15 years [range, 12-18 years]) who were hospitalized for management of myocarditis after receiving the BNT162b2 (Pfizer) vaccine.
More frequently, boys were affected after the second vaccine dose; ventricular systolic dysfunction was recorded in three cases, and in 12 patients, late gadolinium enhancement was evident on cardiac magnetic resonance imaging.
No mortality was recorded, and normal echocardiogram results were recorded in all but 1 patient on follow-up 1 to 13 days after discharge.
Overall, there has been a benign short-term course of COVID-19 vaccine-associated myocarditis in children.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries